Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Blogs & Articles

RapidPV: Delivering Safety Databases at Speed

Mladen Prenc2026-09-17T12:32:31+00:00September 17, 2026| Read More

7 Reasons to Attend Breakthrough 2027: Gain the Decision Advantage

Mladen Prenc2026-09-04T09:29:17+00:00September 4, 2026| Read More

Enhancing Your Existing RIM System with Modular, AI-Powered Innovation

Mladen Prenc2026-04-20T15:20:48+00:00April 20, 2026| Read More

Navigating the Next Era of PV Innovation: Autonomous Intelligence, powered by Agentic AI

Mladen Prenc2026-04-08T18:44:12+00:00April 8, 2026| Read More

EMA & FDA Alignment on ISO IDMP: Transforming the E2B Safety Database Landscape

Mladen Prenc2026-01-20T14:28:27+00:00January 20, 2026| Read More

Guiding principles: how new CIOMS XIV guidance will accelerate trusted AI use in regulated contexts

Mladen Prenc2026-01-29T19:22:32+00:00January 15, 2026| Read More

AI in PV case intake & processing: where are we now?

Mladen Prenc2026-01-09T10:24:29+00:00January 9, 2026| Read More

Agentic AI in Pharmacovigilance Checklist

Mladen Prenc2026-04-09T09:21:04+00:00January 9, 2026| Read More

How AI and Automation Improve the Entire PV Ecosystem

Mladen Prenc2025-12-04T15:51:45+00:00December 4, 2025| Read More

How to Make Your Case to Attend Breakthrough 2026

fcampbell@arisglobal.com2025-11-11T09:04:56+00:00November 3, 2025| Read More

Operationalizing AI Across the End-to-End Safety Ecosystem

Mladen Prenc2025-11-05T11:29:21+00:00October 15, 2025| Read More

5 Reasons You Can’t Miss Breakthrough 2026

Mladen Prenc2025-10-21T15:31:49+00:00September 22, 2025| Read More

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.